Pacific Biosciences of California Inc. buy Cantor Fitzgerald
Start price
08.08.24
/
50%
€1.41
Target price
08.08.25
€3.21
Performance (%)
-19.66%
End price
09.08.25
€1.13
Summary
This prediction ended on 09.08.25 with a price of €1.13. The price of Pacific Biosciences of California Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.66%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacific Biosciences of California Inc. | -9.471% | -9.471% | -3.408% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $3.50 price target on the stock.
Ratings data for PACB provided by MarketBeat
In the thread Trading Pacific Biosciences of California Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€6.27
31.10.23
31.10.23
€10.36
31.10.24
31.10.24
-68.90%
01.11.24
01.11.24
